Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Decreased Body Temperature01:29

Decreased Body Temperature

A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by sustained extreme cold exposure, and severe...
Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex differences in imaging features including cerebral amyloid angiopathy markers in intracerebral hemorrhage.

Frontiers in stroke·2026
Same author

First World Health Organization resolution on stroke at the Seventy-ninth World Health Assembly: A turning point for global stroke prevention, care, and health-system readiness.

International journal of stroke : official journal of the International Stroke Society·2026
Same author

The Latest Global Stroke Fact Sheet 1990-2023: Global Burden of Disease Study.

Neuroepidemiology·2026
Same author

Changes in long-term survival after stroke between 2013 and 2020: A Nationwide cohort study from the Swedish Stroke Register.

International journal of stroke : official journal of the International Stroke Society·2026
Same author

The importance of advocacy in advancing stroke care: The global stroke action coalition.

International journal of stroke : official journal of the International Stroke Society·2026
Same author

Early versus delayed anticoagulation in acute ischemic stroke with atrial fibrillation according to infarct volume and location: A prespecified subgroup analysis of the OPTIMAS randomized controlled trial.

International journal of stroke : official journal of the International Stroke Society·2026

Related Experiment Video

Updated: Jun 6, 2026

Short-Duration Hypothermia Induction in Rats using Models for Studies examining Clinical Relevance and Mechanisms
05:00

Short-Duration Hypothermia Induction in Rats using Models for Studies examining Clinical Relevance and Mechanisms

Published on: March 3, 2021

Hypothermia for Stroke: call to action 2010.

Malcolm R Macleod1, Jesper Petersson, Bo Norrving

  • 1Department of Clinical Neurosciences, University of Edinburgh,Western General Hospital, Edinburgh, UK.

International Journal of Stroke : Official Journal of the International Stroke Society
|November 20, 2010
PubMed
Summary

Therapeutic hypothermia shows promise as a novel stroke treatment. A research agenda was defined to assess cooling benefits, aiming for broad implementation in European healthcare systems.

More Related Videos

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
06:43

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management

Published on: November 21, 2017

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
08:22

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model

Published on: October 27, 2020

Related Experiment Videos

Last Updated: Jun 6, 2026

Short-Duration Hypothermia Induction in Rats using Models for Studies examining Clinical Relevance and Mechanisms
05:00

Short-Duration Hypothermia Induction in Rats using Models for Studies examining Clinical Relevance and Mechanisms

Published on: March 3, 2021

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
06:43

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management

Published on: November 21, 2017

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
08:22

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model

Published on: October 27, 2020

Area of Science:

  • Neurology
  • Cardiovascular Diseases
  • Emergency Medicine

Background:

  • Global increase in stroke incidence necessitates novel therapeutic strategies.
  • Current thrombolytic treatment eligibility remains limited to a small patient subset.
  • Therapeutic hypothermia presents a potential cost-effective and broadly applicable treatment option.

Framework:

  • The European Hypothermia Stroke Research Workshop (January 2010) established a research agenda for therapeutic hypothermia in acute ischemic stroke.
  • The 'Hypothermia for Stroke--Call to Action 2010' declaration outlines research priorities.
  • Collaboration involved key stroke organizations, cryobiology, and European space and enterprise sectors.

Implementation:

  • A research program integrating Phase II and III clinical trials is proposed.
  • Phase II studies will optimize cooling parameters: depth, duration, mode, antishivering strategies, and patient selection.
  • A pivotal Phase III trial will validate the optimized intervention's effectiveness.

Implications:

  • Successful validation could establish therapeutic cooling as a standard stroke treatment.
  • Evidence-based Clinical Practice Guidelines will be developed for optimal hypothermia use.
  • This research aims to benefit a large number of acute ischemic stroke patients.